The research article presents the treatment and prognosis of antibody-mediated rejection of the transplanted kidney at the Kidney Transplantation Centre of the University Medical Centre Ljubljana and underlines the importance of early detection and treatment of antibody-mediated rejection to improve long-term survival following kidney transplantation.
COBISS.SI-ID: 3277228
An increase in spot urine protein excretion before kidney graft dysfunction appears to be associated with graft rejection and predicts antibody-mediated rejection phenotype.
COBISS.SI-ID: 3994284
The objective of this review was to provide contemporary data on the diagnostic role of laboratory test-based functional monitoring assays that can be used in everyday clinical practice and use non-invasive samples, such as peripheral blood or spot urine samples that might help distinguish rejection versus non-rejection episodes and between different rejection phenotypes as well as to predict functional recovery after anti-rejection therapy.
COBISS.SI-ID: 2885292
Prospective, randomised, double-blind, placebo-controlled study demonstrated that in kidney transplant recipients addition paricalcitol lowers residual proteinuria, and could be used as an effective approach to lower allograft failure risk.
COBISS.SI-ID: 5134252
The results of this prospective, randomised study demonstrated that in kidney transplant recipients, addition of paricalcitol lowers proteinuria, IL-6 and TGF-beta concentrations, which may be beneficial for reducing graft inflammation and fibrosis.
COBISS.SI-ID: 3993516